IP Library › Assignment 055693/0882
Patent Assignment
Reel/Frame 055693/0882

Assignment of Assignor's Interest

Recorded: 2021-03-23 Pages: 62
Assignor
SAMUMED, LLC
Executed: 2021-03-05
Assignee
BIOSPLICE THERAPEUTICS, INC.
9360 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (50)
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 8,252,812 →
Application: 12/852,706 →
Publication: US 2011/0034497
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 8,450,340 →
Application: 12/968,505 →
Publication: US 2011/0190290
Beta- and Gamma-Diketones and Gamma-Hydroxyketones as Wnt/Beta-Catenin Signaling Pathway Activators
Patent: 8,609,717 →
Application: 13/211,665 →
Publication: US 2012/0046320
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 8,822,478 →
Application: 13/552,188 →
Publication: US 2013/0040976
INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/Beta-CATENIN SIGNALING PATHWAY INHIBITORS
Patent: 9,221,793 →
Application: 13/614,296 →
Publication: US 2013/0079329
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 8,673,936 →
Application: 13/800,963 →
Publication: US 2013/0267495
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 8,815,897 →
Application: 13/855,874 →
Publication: US 2013/0225576
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 8,883,822 →
Application: 13/887,177 →
Publication: US 2013/0296302
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 8,604,052 →
Application: 13/938,691 →
Publication: US 2013/0296341
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 8,846,714 →
Application: 13/938,692 →
Publication: US 2013/0296307
B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators
Patent: 8,629,176 →
Application: 14/019,092 →
Publication: US 2014/0005228
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 8,703,794 →
Application: 14/019,103 →
Publication: US 2014/0005206
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 8,618,128 →
Application: 14/019,147 →
Publication: US 2014/0005383
Indazole-3-Carboxamides and Their Use as Wnt/Beta-Catenin Signaling Pathway Inhibitors
Patent: 8,697,887 →
Application: 14/019,229 →
Publication: US 2014/0045815
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 8,664,241 →
Application: 14/019,940 →
Publication: US 2014/0005170
B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS
Patent: 8,921,413 →
Application: 14/086,529 →
Publication: US 2014/0080902
3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof
Patent: 9,908,867 →
Application: 14/149,948 →
Publication: US 2014/0194441
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 8,987,298 →
Application: 14/178,749 →
Publication: US 2014/0179696
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
Patent: 9,533,976 →
Application: 14/187,063 →
Publication: US 2014/0243349
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 8,901,150 →
Application: 14/331,427 →
Publication: US 2014/0323479
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 9,090,613 →
Application: 14/334,005 →
Publication: US 2015/0045379
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 9,012,472 →
Application: 14/454,279 →
Publication: US 2015/0072981
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 9,067,939 →
Application: 14/465,056 →
Publication: US 2015/0045360
B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS
Patent: 9,303,010 →
Application: 14/547,858 →
Publication: US 2015/0299174
B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS
Patent: 9,493,437 →
Application: 14/547,951 →
Publication: US 2015/0299157
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 9,199,991 →
Application: 14/621,195 →
Publication: US 2015/0152105
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 9,233,104 →
Application: 14/621,222 →
Publication: US 2015/0150862
5-Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
Patent: 9,745,271 →
Application: 14/664,517 →
Publication: US 2015/0266825
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 9,446,035 →
Application: 14/718,354 →
Publication: US 2016/0101092
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 9,381,192 →
Application: 14/741,645 →
Publication: US 2016/0128991
Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles
Patent: 9,795,550 →
Application: 14/831,456 →
Publication: US 2016/0206540
2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof
Patent: 9,475,807 →
Application: 14/847,259 →
Publication: US 2016/0075701
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Patent: 9,540,398 →
Application: 14/847,287 →
Publication: US 2016/0068547
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Patent: 9,657,016 →
Application: 14/847,299 →
Publication: US 2016/0068529
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof
Patent: 9,738,638 →
Application: 14/847,336 →
Publication: US 2016/0090380
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Patent: 9,475,825 →
Application: 14/847,344 →
Publication: US 2016/0068548
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
Patent: 9,493,487 →
Application: 14/847,371 →
Publication: US 2016/0068549
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
Patent: 9,758,531 →
Application: 14/847,379 →
Publication: US 2016/0068550
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Patent: 9,546,185 →
Application: 14/847,394 →
Publication: US 2016/0068551
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 9,994,563 →
Application: 14/939,434 →
Publication: US 2016/0297812
Indazole-3-Carboxamides and Their Use as Wnt/Beta-Catenin Signaling Pathway Inhibitors
Patent: 9,802,916 →
Application: 14/940,958 →
Publication: US 2016/0304488
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 9,586,977 →
Application: 14/962,681 →
Publication: US 2016/0318954
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Patent: 9,763,927 →
Application: 15/184,553 →
Publication: US 2017/0065574
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Patent: 9,855,272 →
Application: 15/244,687 →
Publication: US 2017/0202846
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Patent: 9,763,951 →
Application: 15/257,398 →
Publication: US 2017/0216299
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
Patent: 9,889,140 →
Application: 15/267,939 →
Publication: US 2017/0224697
2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof
Patent: 9,828,372 →
Application: 15/298,346 →
Publication: US 2017/0260179
B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS
Patent: 9,884,053 →
Application: 15/349,118 →
Publication: US 2017/0246154
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
Patent: 9,951,053 →
Application: 15/356,903 →
Publication: US 2017/0260176
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Patent: 9,815,854 →
Application: 15/357,494 →
Publication: US 2017/0260209
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 24, 2010
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: EPITHERIX, LLC
Reel/Frame 024875/0129 →
Assignment of Assignor's Interest Apr 13, 2011
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: EPITHERIX, LLC
Reel/Frame 026115/0438 →
Assignment of Assignor's Interest Oct 10, 2011
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.
To: WINTHERIX LLC
Reel/Frame 027036/0295 →
Merger Jun 26, 2012
From: WINTHERIX, LLC
To: SAMUMED, LLC
Reel/Frame 028442/0313 →
Assignment of Assignor's Interest Jun 26, 2012
From: EPITHERIX, LLC
To: SAMUMED, LLC
Reel/Frame 028442/0355 →
Assignment of Assignor's Interest Aug 9, 2012
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 028756/0033 →
Assignment of Assignor's Interest Dec 10, 2012
From: HOOD, JOHN; KUMAR KC, SUNIL
To: SAMUMED, LLC
Reel/Frame 029436/0421 →
Assignment of Assignor's Interest Jun 13, 2013
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 030607/0672 →
Assignment of Assignor's Interest Jun 21, 2013
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 030662/0508 →
Assignment of Assignor's Interest Jul 2, 2013
From: EPITHERIX, LLC
To: SAMUMED, LLC
Reel/Frame 030724/0797 →
Assignment of Assignor's Interest Jul 2, 2013
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: EPITHERIX, LLC
Reel/Frame 030724/0774 →
Assignment of Assignor's Interest Aug 6, 2013
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: EPITHERIX, LLC
Reel/Frame 030946/0566 →
Assignment of Assignor's Interest Aug 6, 2013
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 030947/0392 →
Assignment of Assignor's Interest Aug 6, 2013
From: EPITHERIX, LLC
To: SAMUMED, LLC
Reel/Frame 030946/0591 →
Assignment of Assignor's Interest Oct 11, 2013
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.
To: WINTHERIX LLC
Reel/Frame 031389/0916 →
Assignment of Assignor's Interest Oct 11, 2013
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 031387/0729 →
Merger Oct 11, 2013
From: WINTHERIX, LLC
To: SAMUMED, LLC
Reel/Frame 031389/0977 →
Assignment of Assignor's Interest Oct 15, 2013
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 031403/0124 →
Assignment of Assignor's Interest Oct 15, 2013
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 031403/0462 →
Assignment of Assignor's Interest Oct 15, 2013
From: HOOD, JOHN; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 031403/0427 →
Assignment of Assignor's Interest Dec 13, 2013
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.
To: SAMUMED, LLC
Reel/Frame 031780/0868 →
Assignment of Assignor's Interest Feb 12, 2014
From: KC, SUNIL KUMAR; HOOD, JOHN
To: SAMUMED, LLC
Reel/Frame 032200/0146 →
Assignment of Assignor's Interest Jul 8, 2015
From: KC, SUNIL KUMAR; HOOD, JOHN
To: SAMUMED, LLC
Reel/Frame 036025/0001 →
Assignment of Assignor's Interest Feb 23, 2021
From: HOOD, JOHN; WALLACE, DAVID MARK; KUMAR KC, SUNIL
To: SAMUMED, LLC
Reel/Frame 055375/0764 →
Security Interest Sep 14, 2022
From: BIOSPLICE THERAPEUTICS, INC.
To: VICKERS VENTURE FUND VI PTE. LTD.; VICKERS VENTURE FUND VI (PLAN) PTE. LTD.; VICKERS-SPLICE CO-INVESTMENT LLC; MED-PATHWAYS II LIMITED
Reel/Frame 061433/0786 →